Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.250
-0.110 (-4.66%)
At close: Jul 20, 2026, 4:00 PM EDT
2.340
+0.090 (4.00%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $142.55 million as of July 20, 2026. Its market cap has increased by 103.64% in one year.
Market Cap
142.55M
Enterprise Value
119.79M
1-Year Change
103.64%
Ranking
Category
Stock Price
$2.25
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $142.55M, a decrease of -72.78%. That is a compound annual growth rate of -23.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 142.55M | 99.08% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 155.78M |
| Kazia Therapeutics | 151.52M |
| PepGen | 151.13M |
| Molecular Partners AG | 146.99M |
| Unicycive Therapeutics | 145.73M |
| TuHURA Biosciences | 142.01M |
| Connect Biopharma Holdings | 140.41M |
| Cibus | 135.11M |